[A new method of clinical evaluation of the results of drug resistance determination].
D000328:Adult; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005000:Ethionamide / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008722:Methods; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification / Q000472:pathogenicity; D013183:Sputum / Q000382:microbiology; D013307:Streptomycin / Q000627:therapeutic use; D014756:Viomycin / Q000627:therapeutic use
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin; D014756:Viomycin
Eine neue Methode zur Bewertung der Ergebnisse der Resistenzbestimmung in der Klinik.